فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

aop orphan pharmaceuticals gmbh - tadalafil - tabletti, kalvopäällysteinen - 20 mg - tadalafiili

الاتحاد الأوروبي - الفنلندية - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv-infektiot - antiviraalit systeemiseen käyttöön - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

الاتحاد الأوروبي - الفنلندية - EMA (European Medicines Agency)

roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - silmätautien - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).

فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

b. braun melsungen ag - gentamicini sulfas - infuusioneste, liuos - 1 mg/ml - gentamisiini

فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

b. braun melsungen ag - gentamicini sulfas - infuusioneste, liuos - 3 mg/ml - gentamisiini

الاتحاد الأوروبي - الفنلندية - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - kystinen fibroosi - muut hengitysteiden tuotteet - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.

الاتحاد الأوروبي - الفنلندية - EMA (European Medicines Agency)

bpl bioproducts laboratory gmbh - ihmisen hyytymistekijä x - faktorin x puute - vitamin k and other hemostatics, antihemorrhagics, coagulation factor x - coagadex on tarkoitettu verenvuototapahtumien hoitoon ja ennaltaehkäisyyn sekä perioperatiiviseen hoitoon potilailla, joilla on perinnöllinen tekijä x-puutos. coagadex on tarkoitettu kaikille ikäryhmille.

الاتحاد الأوروبي - الفنلندية - EMA (European Medicines Agency)

gilead sciences ireland uc - sofosbuvir, velpatasvir - hepatiitti c, krooninen - antiviraalit systeemiseen käyttöön - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 ja 5.

الاتحاد الأوروبي - الفنلندية - EMA (European Medicines Agency)

instituto grifols s.a. - ihmisen normaali immunoglobuliini - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - immunoseerumit ja immunoglobuliinit, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.

الاتحاد الأوروبي - الفنلندية - EMA (European Medicines Agency)

dechra regulatory b.v. - meloksikaami - musculo-skeletal system, anti-inflammatory and anti-rheumatic products, non-steroids - dogs; cats - catsalleviation tulehdus ja kipu krooninen tuki-ja liikuntaelinten sairaudet. dogsalleviation tulehdusta ja kipua sekä akuuteissa ja kroonisissa tuki-ja liikuntaelinsairauksissa.